The 2019/2020 annual report is now out
We are committed to therapeutic progress to serve patient needs with the help of healthcare professionals. We strive to provide future generations with a world where quality healthcare is available and accessible to all.
Discover our 4 values:
Dare to innovate:
We undertake to provide innovative therapeutic solutions. Driven by a pioneering spirit, we dare, we strive, and we accomplish together.
We prepare for the future by embracing human and environmental dimensions. Our concern for the health and fulfillment of all is our driving force.
Grow by sharing
Every opportunity to work together contributes to the common good. Whoever we are, wherever we are, we grow and develop by working together, building on one another’s experiences and contributions.
Commit to succeed:
The continuous development of the Group is vital. Whatever challenges we face, we are committed to keeping our promises.
OUR THERAPEUTIC AREAS
Our R&D is specialized in 5 areas: cardiovascular, diabetes, cancer, immuno-inflammatory and neuropsychiatric diseases.. Within each of them, the Group has chosen to specialize in a limited number of pathologies where the medical needs are still great.
patients treated each day
worldwide with Servier
of revenue from brand-name
medicines invested in
R&D in 2019/2020.
€4.7 billion euros
euros in revenue in 2019/2020 comprising
€3.3 billion for brand-name medicines
and €1.4 billion for generic medicines.
3 therapeutic areas
oncology, immune-inflammatory and
Servier Medical Art is a medical image bank that we make available to illustrate your medical releases.
Servier Laboratories South Africa (Pty) Ltd
Building 4, Country Club Estate
21 Woodlands Drive, Woodmead, 2191
Tel: +27 (0) 861 700 900
Tel: +27 (0) 11 525 3400
Fax: +27 (0) 11 525 3401